No results for ‘’
Phaarmasia Ltd
₹99.28
(5.00%)
Wed, 24 Jun 2026, 07:38 pm
Health Technology
Pharmaceuticals: Major
24.5KPhaarmasia Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 670.37 | 1580 | 1550 | 535.91 | 57.85 | 12.50 | 61.95 | 530.83 | 72.71 | 43.75 | 14.79 | 17.58 | 54.38 | 0 | 0 | 0 | 0 |
| Price to book ratio | 26.50 | 19.85 | 18.16 | 15.43 | 1.37 | 0.60 | 0.65 | 1.83 | 1.02 | 2.09 | 0.90 | 0.71 | 1.24 | 1.75 | 1.48 | 1.93 | 2.29 |
| Price to sales ratio | 22.93 | 18.11 | 3.26 | 3.49 | 1.48 | 0.29 | 0.45 | 1.01 | 0.83 | 1.24 | 0.48 | 0.39 | 0.86 | 1.25 | 0.58 | 0.65 | 0.82 |
| Price to cash flow ratio | 1220 | 557.65 | 71.24 | 0 | 100.78 | 25.44 | 18.98 | 81.02 | 0 | 28.52 | 204.61 | 118.47 | 67.88 | 0 | 24.08 | 209.56 | 727.63 |
| Enterprise value | 247Cr | 173Cr | 146Cr | 121Cr | 10.24Cr | 4.42Cr | 8.29Cr | 21.39Cr | 11.83Cr | 25.12Cr | 11.51Cr | 9.42Cr | 16.63Cr | 20.94Cr | 15.55Cr | 19.38Cr | 19.66Cr |
| Enterprise value to EBITDA ratio | 247.82 | 255.59 | 202.80 | 115.55 | 15.71 | 5.27 | 8.66 | 98.49 | 89.45 | 38.16 | 15.87 | 11.51 | 0 | 0 | 0 | 0 | 0 |
| Debt to equity ratio | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0 | 0 | 0.02 | 0.01 | 0 |
| Return on equity % | 0 | 1.20 | 1.11 | 2.80 | 2.30 | 4.71 | 1.36 | 0.33 | 1.38 | 4.77 | 6.26 | 4.12 | 2.31 | -12.03 | -11.01 | -4.91 | -16.70 |
Phaarmasia Ltd Enterprise Value
The Phaarmasia Ltd Enterprise Value is a key financial metric used by investors to evaluate Phaarmasia Ltd's valuation, profitability, and overall financial performance. Tracking the Phaarmasia Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Phaarmasia Ltd (NSE: , BSE: 523620) is currently trading at ₹99.28, with a market capitalization of ₹67.78Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the Phaarmasia Ltd Enterprise Value is essential for fundamental analysis.
Phaarmasia Ltd Enterprise Value Current Value
The current Phaarmasia Ltd Enterprise Value stands at 19.66Cr.
The latest Phaarmasia Ltd Enterprise Value has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Phaarmasia Ltd Enterprise Value Historical Trend
The Phaarmasia Ltd Enterprise Value has shown the following historical trend:
- 2024: 19.66Cr
- 2023: 19.38Cr
- 2022: 15.55Cr
- 2021: 20.94Cr
- 2020: 16.63Cr
The recent rise in Phaarmasia Ltd Enterprise Value suggests strengthening valuation trends and improving market sentiment.
What Phaarmasia Ltd Enterprise Value Indicates for Investors
The Phaarmasia Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Phaarmasia Ltd.
Phaarmasia Ltd Enterprise Value Analysis Summary
The Phaarmasia Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Phaarmasia Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Phaarmasia Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.